Pilot Validation Study of the Japanese Translation of the Brief Negative Symptoms Scale (BNSS)

QR Code

Pilot Validation Study of the Japanese Translation of the Brief Negative Symptoms Scale (BNSS)

Naoki Hashimoto,1 Atsuhito Toyomaki,1 Matsuhiko Oka,1 Keisuke Takanobu,1 Ryo Okubo,2 Hisashi Narita,1 Kan Kitagawa,1 Niki Udo,1 Tamaki Maeda,1 Shinya Watanabe,1 Yuka Oyanagi,1 Akane Miyazaki,1 Koki Ito,1 Ichiro Kusumi1 1Department of Psychiatry, Hokkaido University Graduate School of Medicine, Sappo...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Hashimoto N, Toyomaki A, Oka M, Takanobu K, Okubo R, Narita H, Kitagawa K, Udo N, Maeda T, Watanabe S, Oyanagi Y, Miyazaki A, Ito K, Kusumi I
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2019
Sujets:	negative symptom schizophrenia scale factor structure Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Accès en ligne:	https://doaj.org/article/cec34cc65b3d4272b3458c0487dd1b9b
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Validation of the Dutch Version of the Brief Negative Symptom Scale
par: Seelen-de Lang BL, et autres
Publié: (2020)

Elevated activity of superoxide dismutase in male late-life schizophrenia and its correlation with clinical symptoms and cognitive deficits
par: Lijuan Huo, et autres
Publié: (2021)

Cariprazine: Patients with Treatment-Resistant Schizophrenia
par: Aubel T
Publié: (2021)

Case Report: Cariprazine Efficacy in Young Patients Diagnosed With Schizophrenia With Predominantly Negative Symptoms
par: Octavian Vasiliu
Publié: (2021)

Adjunctive simvastatin treatment in schizophrenia patients; a double blind randomized and placebo controlled trial
par: Somaieh Ashrafi, et autres
Publié: (2022)

Negative Symptoms of Schizophrenia: New Prospects of Cariprazine Treatment
par: Aleksandr M. Reznik, et autres
Publié: (2020)

Effectiveness of amisulpride in Chinese patients with predominantly negative symptoms of schizophrenia: a subanalysis of the ESCAPE study
par: Liang Y, et autres
Publié: (2017)

The Relationship Between Antipsychotic Treatment and Plasma β-Endorphin Concentration in Patients with Schizophrenia
par: Urban-Kowalczyk M, et autres
Publié: (2021)

Validation of the Chinese Version of the 16-Item Negative Symptom Assessment
par: Huang B, et autres
Publié: (2020)

Cariprazine in Three Acute Patients with Schizophrenia: A Real-World Experience
par: Montes JM, et autres
Publié: (2021)

Relationship between social and cognitive functions in people with schizophrenia
par: Tominaga T, et autres
Publié: (2018)

Online Left-Hemispheric In-Phase Frontoparietal Theta tACS for the Treatment of Negative Symptoms of Schizophrenia
par: Chuan-Chia Chang, et autres
Publié: (2021)

Negative Symptoms in Schizophrenia: A Review and Clinical Guide for Recognition, Assessment, and Treatment
par: Correll CU, et autres
Publié: (2020)

Suicidality, self-stigma, social anxiety and personality traits in stabilized schizophrenia patients – a cross-sectional study
par: Vrbova K, et autres
Publié: (2018)

Influence of CFH gene on symptom severity of schizophrenia
par: Zhang C, et autres
Publié: (2017)

Repetitive transcranial magnetic stimulation as an adjunctive treatment for negative symptoms and cognitive impairment in patients with schizophrenia: a randomized, double-blind, sham-controlled trial
par: Zhuo K, et autres
Publié: (2019)

Decline in Psychotic Symptoms in Addition to Cardiac and Metabolic Safety with Cariprazine After Poor Response to Previous Antipsychotic Treatments – A Series of Two Cases
par: Müller HHO, et autres
Publié: (2021)

Comparison of beta-endorphin and CGRP levels before and after treatment for severe schizophrenia
par: Urban-Kowalczyk M, et autres
Publié: (2016)

Cognitive dysfunction and negative symptoms in patients with schizophrenia and their first-degree relatives from simplex and multiplex families
par: Zhang Z, et autres
Publié: (2018)

Absent activation in medial prefrontal cortex and temporoparietal junction but not superior temporal sulcus during the perception of biological motion in schizophrenia: a functional MRI study
par: Hashimoto N, et autres
Publié: (2014)

The Effects of Recreation Therapy on the Habit of Smoking and Positive–Negative Symptoms Among Patients with Chronic Schizophrenia
par: Pirbalouti M. G., et autres
Publié: (2017)

Short-term functional outcome in psychotic patients: results of the Turku early psychosis study (TEPS)
par: Raimo K. R. Salokangas, et autres
Publié: (2021)

Highly Suspected COVID-19 Cluster with Multiple Negative SARS-CoV-2 RNA Tests: A Case Report
par: Huang X, et autres
Publié: (2021)

Effect of Switching to Brexpiprazole on Plasma Homovanillic Acid Levels and Antipsychotic-Related Side Effects in Patients with Schizophrenia or Schizoaffective Disorder
par: Ichinose M, et autres
Publié: (2021)

Schizophrenia and toxoplasmosis: association with catatonic symptoms
par: Dmitry V. Romanov, et autres
Publié: (2020)

Associations between the mismatch-negativity component and symptom severity in children and adolescents with attention deficit/hyperactivity disorder
par: Yamamuro K, et autres
Publié: (2016)

Aberrant Learned Irrelevance in Patients with First-Episode Schizophrenia-Spectrum Disorder
par: Ryan Sai-Ting Chu, et autres
Publié: (2021)

Duration Mismatch Negativity Predicts Remission in First-Episode Schizophrenia Patients
par: Suguru Nakajima, et autres
Publié: (2021)

Comparative efficacy and safety of antipsychotics in the treatment of schizophrenia: a network meta-analysis in a Japanese population
par: Kishi T, et autres
Publié: (2017)

Increased Plasma Kynurenic Acid Levels are Associated with Impaired Attention/Vigilance and Social Cognition in Patients with Schizophrenia
par: Huang X, et autres
Publié: (2020)

Validation of the Chinese version of Brief Assessment of Cognition in Schizophrenia
par: Wang LJ, et autres
Publié: (2016)

Odor perception and hedonics in chronic schizophrenia and in first episode psychosis
par: Urban-Kowalczyk M, et autres
Publié: (2019)

A Brief, Individualized Exercise Program at Intensities Below the Ventilatory Threshold Exerts Therapeutic Effects for Depression: A Pilot Study
par: Yuri Sakai, et autres
Publié: (2021)

Metacognitive Beliefs, Cognitive Functioning, Psychiatric Symptoms and Empathy in People with Schizophrenia
par: Chuang SP, et autres
Publié: (2021)

Correlation of Health-Related Quality of Life in Clinically Stable Outpatients with Schizophrenia
par: Domenech C, et autres
Publié: (2019)

The Yamaguchi fox/pigeon-imitation test, a brief cognitive performance rating tool, in a community-dwelling population: normative data for Japanese subjects – a preliminary study
par: Ishioka M, et autres
Publié: (2014)

Improvement of Negative Symptoms in Schizophrenia with Paliperidone Palmitate 1-Month and 3-Month Long-Acting Injectables: Results from a Phase 3 Non-Inferiority Study
par: Gopal S, et autres
Publié: (2020)

Negative and positive self-thoughts predict subjective quality of life in people with schizophrenia
par: Takeda T, et autres
Publié: (2019)

Measuring negative symptoms in patients with schizophrenia: reliability and validity of the Korean version of the Motivation and Pleasure Scale-Self-Report
par: Kim JS, et autres
Publié: (2016)

Relationship Between Cognitive and Clinical Insight at Different Durations of Untreated Attentional Psychotic Symptoms in High-Risk Individuals
par: LiHua Xu, et autres
Publié: (2021)